ERIN GENOVA: Open Payments
NPI 1033602214 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 27 payments from 10 companies in 2025. Trend: 2023 $895 · 2024 $1,434 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $365 |
| Amgen Inc. | 4 | $167 |
| PFIZER INC. | 5 | $91 |
| Exact Sciences Corporation | 3 | $63 |
| Lilly USA, LLC | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: QULIPTA, EVENITY, NURTEC ODT, The Cologuard Plus Collection Kit, OTEZLA, TZIELD, SHINGRIX, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
